Om

SL Science Holding Limited is a biotechnology holding company focused on developing cell and gene therapies for regenerative medicine and oncology. Its current portfolio centers on investigational immune cell technologies, including armed T-cell and gamma delta T-cell programs, alongside exosome-based products derived from non-human sources such as plants and bovine milk. The company operates as a platform for advancing next-generation biomedical solutions and supports research across cancer treatment and regenerative applications. SL Science Holding Limited is positioned as a science-driven company that combines therapeutic development with a broader focus on specialized biological products for medical and consumer uses.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I SL SCIENCE HOLDING MED ENDAVU: Køb SL Science Holding ($SLBT) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i SL Science Holding, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.